Emcure Pharma Announces Strong Q3FY25 with 18% Revenue Growth and 30% Profit After Tax Growth’ administrator admin Date 06 February, 2025 Share: Prev Cricket Icon MS Dhoni and Emcure’s Namita Thapar Unite to Champion Women’s Health Awareness Emcure Expands OTC Portfolio with Arth Supplements, Welcomes Vidya Balan as Brand Ambassador Next
